4.8 Article

Molecular Basis for the Regulation of the H3K4 Methyltransferase Activity of PRDM9

期刊

CELL REPORTS
卷 5, 期 1, 页码 13-20

出版社

CELL PRESS
DOI: 10.1016/j.celrep.2013.08.035

关键词

-

资金

  1. EU
  2. Centre National de la Recherche Scientifique
  3. Agence Nationale de la Recherche [09-BLAN-0269-01]
  4. Fondation pour la Recherche Medicale
  5. AbbVie
  6. Boehringer Ingelheim
  7. Canada Foundation for Innovation
  8. Canadian Institutes for Health Research
  9. Genome Canada through the Ontario Genomics Institute [OGI-055]
  10. GlaxoSmithKline
  11. GlaxoSmithKline, Janssen
  12. Lilly Canada
  13. Novartis Research Foundation
  14. Ontario Ministry of Economic Development and Innovation
  15. Pfizer
  16. Takeda
  17. Wellcome Trust [092809/Z/10/Z]

向作者/读者索取更多资源

PRDM9, a histone lysine methyltransferase, is a key determinant of the localization of meiotic recombination hot spots in humans and mice and the only vertebrate protein known to be involved in hybrid sterility. Here, we report the crystal structure of the PRDM9 methyltransferase domain in complex with a histone H3 peptide dimethylated on lysine 4 (H3K4me2) and S-adenosylhomocysteine (AdoHcy), which provides insights into the methyltransferase activity of PRDM proteins. We show that the genuine substrate of PRDM9 is histone H3 lysine 4 (H3K4) and that the enzyme possesses mono-, di-, and trimethylation activities. We also determined the crystal structure of PRDM9 in its autoinhibited state, which revealed a rearrangement of the substrate and cofactor binding sites by a concerted action of the pre-SET and post-SET domains, providing important insights into the regulatory mechanisms of histone lysine methyltransferase activity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据